These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9721237)

  • 21. Influence of additional acylation site(s) of influenza B virus hemagglutinin on syncytium formation.
    Ujike M; Nakajima K; Nobusawa E
    Microbiol Immunol; 2005; 49(4):355-9. PubMed ID: 15840961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin.
    Skehel JJ; Wiley DC
    Annu Rev Biochem; 2000; 69():531-69. PubMed ID: 10966468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A polar octapeptide fused to the N-terminal fusion peptide solubilizes the influenza virus HA2 subunit ectodomain.
    Chen J; Skehel JJ; Wiley DC
    Biochemistry; 1998 Sep; 37(39):13643-9. PubMed ID: 9753451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fusion protein of the paramyxovirus SV5: destabilizing and stabilizing mutants of fusion activation.
    Paterson RG; Russell CJ; Lamb RA
    Virology; 2000 Apr; 270(1):17-30. PubMed ID: 10772976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single residue deletions along the length of the influenza HA fusion peptide lead to inhibition of membrane fusion function.
    Langley WA; Thoennes S; Bradley KC; Galloway SE; Talekar GR; Cummings SF; Varecková E; Russell RJ; Steinhauer DA
    Virology; 2009 Nov; 394(2):321-30. PubMed ID: 19755201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retroviral vector targeting through insertion of epidermal growth factor into receptor binding deficient influenza A hemagglutinin results in fusion defective particles.
    Haynes C; Schnierle BS
    J Virol Methods; 2004 Sep; 120(2):189-99. PubMed ID: 15288962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins.
    Latham T; Galarza JM
    J Virol; 2001 Jul; 75(13):6154-65. PubMed ID: 11390617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigen-specific membrane fusion mediated by the haemagglutinin protein of influenza A virus: separation of attachment and fusion functions on different molecules.
    Patterson SM; Swainsbury R; Routledge EG
    Gene Ther; 1999 Apr; 6(4):694-702. PubMed ID: 10476231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Structure and function of the hemagglutinin of influenza viruses].
    Nobusawa E
    Nihon Rinsho; 1997 Oct; 55(10):2562-9. PubMed ID: 9360372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Active site for fusion activity of influenza virus hemagglutinin].
    Ohuchi M; Ohuchi R
    Nihon Rinsho; 1997 Oct; 55(10):2648-53. PubMed ID: 9360385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Murine leukemia virus R Peptide inhibits influenza virus hemagglutinin-induced membrane fusion.
    Li M; Li ZN; Yao Q; Yang C; Steinhauer DA; Compans RW
    J Virol; 2006 Jun; 80(12):6106-14. PubMed ID: 16731949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leash in the groove mechanism of membrane fusion.
    Park HE; Gruenke JA; White JM
    Nat Struct Biol; 2003 Dec; 10(12):1048-53. PubMed ID: 14595397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A point mutation at the C terminus of the cytoplasmic domain of influenza B virus haemagglutinin inhibits syncytium formation.
    Ujike M; Nakajima K; Nobusawa E
    J Gen Virol; 2006 Jun; 87(Pt 6):1669-1676. PubMed ID: 16690932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Site-specific mutagenesis identifies three cysteine residues in the cytoplasmic tail as acylation sites of influenza virus hemagglutinin.
    Veit M; Kretzschmar E; Kuroda K; Garten W; Schmidt MF; Klenk HD; Rott R
    J Virol; 1991 May; 65(5):2491-500. PubMed ID: 1901916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of pseudotyped retroviral vectors to analyze the receptor-binding pocket of hemagglutinin from a pathogenic avian influenza A virus (H7 subtype).
    Lin AH; Cannon PM
    Virus Res; 2002 Feb; 83(1-2):43-56. PubMed ID: 11864740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of fusion activity of influenza A haemagglutinin mediated by HA2-specific monoclonal antibodies.
    Varecková E; Mucha V; Wharton SA; Kostolanský F
    Arch Virol; 2003 Mar; 148(3):469-86. PubMed ID: 12607099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of Glu11 and Gly8 of the H5N1 influenza hemagglutinin fusion peptide in membrane fusion using pseudotype virus and reverse genetics.
    Su Y; Zhu X; Wang Y; Wu M; Tien P
    Arch Virol; 2008; 153(2):247-57. PubMed ID: 18030546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deacylation of the hemagglutinin of influenza A/Aichi/2/68 has no effect on membrane fusion properties.
    Steinhauer DA; Wharton SA; Wiley DC; Skehel JJ
    Virology; 1991 Sep; 184(1):445-8. PubMed ID: 1871979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Palmitylation of the influenza virus hemagglutinin (H3) is not essential for virus assembly or infectivity.
    Jin H; Subbarao K; Bagai S; Leser GP; Murphy BR; Lamb RA
    J Virol; 1996 Mar; 70(3):1406-14. PubMed ID: 8627657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Change in receptor-binding specificity of recent human influenza A viruses (H3N2): a single amino acid change in hemagglutinin altered its recognition of sialyloligosaccharides.
    Nobusawa E; Ishihara H; Morishita T; Sato K; Nakajima K
    Virology; 2000 Dec; 278(2):587-96. PubMed ID: 11118381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.